Return to search results
Methotrexate
Methotrexate is a prescription oral tablet medication containing 2.5 mg of methotrexate sodium, manufactured by Alembic Pharmaceuticals. It acts as a folate analog metabolic inhibitor, interfering with folic acid processes in the body, and is used for various therapeutic purposes under medical supervision. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Methotrexate is a prescription oral tablet medication containing 2.5 mg of methotrexate sodium, manufactured by Alembic Pharmaceuticals. It acts as a folate analog metabolic inhibitor, interfering with folic acid processes in the body, and is used for various therapeutic purposes under medical supervision. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Methotrexate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Methotrexate — ANDA 207812 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207812"
}
]
|
| identifier | ANDA207812 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Methotrexate |
